Letters to the Editor

An international retrospective study for tolerability of 6-mercaptopurine on NUDT15 bi-allelic variants in children with acute lymphoblastic leukemia

Division of Medicinal Safety Science, National Institute of Health Sciences, Kawasaki
VIVA-NUS Centre of Translational Research in Acute Leukaemia (Molecular), Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
Hong Kong Children’s Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong, Special Administrative Region
Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki
Department of Hematology/Oncology, Saitama Children’s Medical Center, Saitama
Hematology/Oncology Division, Department of Pediatrics Faculty of Medicine, Siriraj Hospital Mahidol University
Department of Hematology and Oncology, Guangzhou Women and Children's Medical Center
Division of Pediatric Hematology-Oncology, Mackay Children's Hospital and Mackay Memorial Hospital, Taipei
Department of Paediatrics, University of Malaya Medical Centre, Kuala Lumpur
VIVA-NUS Centre of Translational Research in Acute Leukaemia (Molecular), Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore
VIVA-NUS Centre of Translational Research in Acute Leukaemia (Molecular), Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
Department of Pediatrics, St. Luke's International Hospital, Tokyo
Department of Pediatrics, Juntendo University, School of Medicine, Tokyo
Department of Pediatrics, St. Marianna University School of Medicine Hospital, Kawasaki
Department of Pediatrics, St. Marianna University School of Medicine Hospital, Kawasaki
Department of Hematology and Oncology, Miyagi Children’s Hospital, Sendai
Department of Pediatrics, Nippon Medical School, Tokyo
Department of Pediatrics, Sapporo Medical University School of Medicine, Sapporo
Department of Hematology/Oncology, Chiba Children’s Hospital, Chiba
Department of Pediatrics, Chiba University Graduate School of Medicine, Chiba
Department of Pediatrics, Tokyo Medical and Dental University, Tokyo
Department of Pediatrics, Toho University School of Medicine, Tokyo
Department of Pediatrics, Hirosaki University Graduate School of Medicine, Hirosaki
Hematology/Oncology Division, Department of Pediatrics Faculty of Medicine, Siriraj Hospital Mahidol University
Department of Pediatrics, Mie University, Tsu, Mie
Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN
Department of Transplantation and Cell Therapy, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan; Department of Pediatric Hematology and Oncology Research, National Center for Child Health and Development, Tokyo, Japan; Department of Pediatrics, the University of Tokyo, Tokyo
Haematologica Early view Jan 28, 2021 https://doi.org/10.3324/haematol.2020.266320